广东东阳光科技控股股份有限公司关于控股股东之一致行动人部分股份质押及解质押的公告

Core Viewpoint - The announcement details the pledge and unpledge of shares by the controlling shareholders and their concerted actions, indicating a significant portion of shares are pledged but do not pose immediate risks to the company's operations or governance [2][6][7]. Group 1: Share Pledge Details - Yichang Dongyangguang Pharmaceutical Co., Ltd. holds 545,023,350 shares, accounting for 18.11% of the total share capital, with 521,650,000 shares pledged, representing 95.71% of its holdings [2]. - Luyuan Yangzhiguang Aluminum Development Co., Ltd. holds 128,058,819 shares, accounting for 4.26% of the total share capital, with 96,000,000 shares pledged, representing 74.97% of its holdings [2]. - Shenzhen Dongyangguang Industrial Development Co., Ltd. has pledged a total of 541,527,254 shares, which is 87.37% of its holdings, while the total pledged shares by controlling shareholders and their concerted actions amount to 1,229,177,254 shares, representing 77.30% of their combined holdings [2][5]. Group 2: Financial Implications - Shenzhen Dongyangguang Industrial has 14,508,940 shares maturing in the next six months, which is 23.41% of its holdings and 4.82% of the total share capital, with a corresponding financing balance of 171,071 million [6]. - Yichang Dongyangguang Pharmaceutical has 9,600,000 shares maturing in the next six months, which is 17.61% of its holdings and 3.19% of the total share capital, with a financing balance of 181,000 million [6]. - Both Shenzhen Dongyangguang Industrial and Yichang Dongyangguang Pharmaceutical have good credit status, with sufficient repayment capabilities from operational income and investment returns [6]. Group 3: Impact on Company Operations - The share pledges will not affect the company's production, financing, or operational capabilities [6][7]. - There are currently no risks of forced liquidation or changes in actual control due to these pledges, ensuring stability in governance and management [7]. - The pledged shares are not used as collateral for major asset restructuring or performance compensation [3][8].